National Research Institute
2010 Wilshire Boulevard
Los Angeles, California 90057
213-413-2500 http://www.clinical-studies.com docl@sbcglobal.net

Use our guide to learn which trials are right for you!

Located in Los Angeles, California, the National Research Institute (NRI) is a privately owned clinical research center providing clinical trial services to the pharmaceutical industry.

Over the past 25 years, NRI has:

Successfully conducted over 275 national and international Phase II, III, and IV clinical trials in therapeutic areas of:

  • Diabetes Type II
  • Hypertension
  • Lipid Metabolism
  • Obesity

Has passed three consecutive FDA audits with no cited protocol deviations or being issued 483's.

Has done very well on numerous sponsors QA audits.

  • Comprehensive mentoring and continuing education programs to assist with onsite and offsite clinical research training
  • Comprehensive SOP's
  • FAA/IATA certified staff for the shipment of hazardous materials
  • GCP/ICH trained staff
  • HIPAA trained and compliant staff
  • Shared care certified (BP)
  • Trained in various centralized 12 lead ECG
  • Trained in ambulatory cardiovascular monitoring (ABPM + Holter Monitoring)

Andrew Lewin, MD
President and Chief Executive Officer

Dr. Lewin serves as Director of NRI, is board certified in Internal Medicine and Nephrology, and has been recognized as a Specialist in Clinical Hypertension by the American Society of Hypertension. He also serves as Associate Professor of Medicine at the UCLA School of Medicine and is an Attending at Cedars-Sinai Medical Center. He has been published extensively in peer-reviewed journals on Hypertension, Diabetes, and Lipid Metabolism. He has also passed a course in Human Subjects Research Training given by the Society of Principal Investigators and in 2003 was designated a Certified Physician Investigator by the American Academy of Pharmaceutical Physicians.

  • Affiliated Physicians, all board certified in their specialties
  • 13 Clinical Research Coordinators
  • Regulatory Department
  • Quality Assurance Department
  • Administrative/Operations Staff
  • Only involved in research protocols
  • Administrative/Operations Staff devoted to research subjects
  • Approximately 33 total staff

95% of NRI's research population is Hispanic.


Cardiology/Vascular Diseases
Endocrinology
Gastroenterology
Nephrology/Urology

  • NRI is housed in a modern 7,000 square foot facility with a certified on-site laboratory
  • Maintains high quality assurance standards through weekly staff meetings, regular review of protocol summaries, rapid response to monitoring questions and company queries, and ongoing internal study audits
  • Has passed three consecutive FDA audits without protocol deviations being cited
  • Maintains a computerized patient tracking system
  • Fully HIPAA Compliant
  • Comprehensive mentoring and continuing education programs to assist with on site clinical research training
  • Comprehensive SOPs
  • IATA certified staff for the shipment of hazardous materials
  • CPR certified staff
  • GCP trained staff
  • HIPAA trained and certified staff
  • Is fluent with RDE (remote data entry)
  • All staff members are bilingual in Spanish
  • Patient recruitment is typically achieved by the following means:
    • Extensive in-house patient database (5000 current research subjects available)
    • Patient referrals
    • Advertising: television, newspaper, radio, etc.

Andrew J. Lewin
President and Chief Executive Officer
National Research Institute
2010 Wilshire Boulevard
Suite 302
Los Angeles, CA 90057
USA
213-413-2500
213-483-1494 (fax)
docl@sbcglobal.net
www.clinical-studies.com


We've found
19 trials
at this facility
Hepatitis C, Chronic Clinical Trial
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Status: Enrolling
Updated: 2/25/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes
Status: Enrolling, Phase II
Updated: 3/21/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling, Phase II
Updated: 9/30/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Status: Enrolling, Phase II
Updated: 3/2/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
Status: Enrolling, Phase II
Updated: 10/10/2014
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Gilead Sustained Virologic Response (SVR) Registry
Status: Enrolling
Updated: 2/25/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Diabetes Clinical Trial
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
Status: Enrolling, Phase III
Updated: 2/25/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Diabetes Clinical Trial
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Without Control on Metformin Alone
Status: Enrolling, Phase III
Updated: 2/25/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
Status: Enrolling, Phase II
Updated: 3/30/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
Status: Enrolling, Phase IV
Updated: 3/28/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Diabetes Type 2 Clinical Trial
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling, Phase II
Updated: 2/1/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Diabetes Mellitus Type 2 Clinical Trial
A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes
Status: Enrolling, Phase II
Updated: 3/11/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
Status: Enrolling, Phase III
Updated: 2/25/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia
Status: Enrolling, Phase III
Updated: 3/21/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Smallpox Clinical Trial
A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Status: Enrolling, Phase III
Updated: 11/30/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 2/18/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 2/10/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/1/1970
mi
from
Los Angeles, CA
Click here to add this to my saved trials